Amgen Inc

AMGN

NASDAQ

Biotechnology

$415.21

USD

-2.63 (-0.63%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $225.90B

Volume 1.7M

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Peer Comparison Table

(1/4)
	AMGN	Amgen Inc	$225.90B	25.84	+9.1%	+2.3%
	GILD	Gilead Sciences, Inc	$169.87B	-	+5.5%	+3.6%
	VRTX	Vertex Pharmaceuticals Inc	$135.24B	30.70	+10.2%	-
	REGN	Regeneron Pharmaceuticals Inc	$82.16B	18.98	+9.3%	+0.5%
	NTRA	Natera Inc	$44.64B	-	+37.8%	-
	RVMD	Revolution Medicines Inc	$43.21B	-	-	-
	BIIB	Biogen Inc	$31.05B	37.20	+0.3%	-

Top Peer by Growth

Natera Inc

+37.8% YoY Revenue

Lowest P/E Ratio

Regeneron Pharmaceuticals Inc

18.98x P/E

Best 1-Year Return

Revolution Medicines Inc

+460.0% Return